Sotera Health Company (SHC)
- Previous Close
12.92 - Open
12.85 - Bid 11.85 x 200
- Ask 13.94 x 200
- Day's Range
12.74 - 13.05 - 52 Week Range
9.53 - 17.08 - Volume
1,268,109 - Avg. Volume
1,317,013 - Market Cap (intraday)
3.648B - Beta (5Y Monthly) 1.89
- PE Ratio (TTM)
142.78 - EPS (TTM)
0.09 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.14
Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
soterahealth.com3,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHC
View More
Performance Overview: SHC
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHC
View MoreValuation Measures
Market Cap
3.67B
Enterprise Value
5.71B
Trailing P/E
143.56
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.32
Price/Book (mrq)
8.86
Enterprise Value/Revenue
5.16
Enterprise Value/EBITDA
13.73
Financial Highlights
Profitability and Income Statement
Profit Margin
2.24%
Return on Assets (ttm)
7.01%
Return on Equity (ttm)
5.88%
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
24.78M
Diluted EPS (ttm)
0.09
Balance Sheet and Cash Flow
Total Cash (mrq)
304.61M
Total Debt/Equity (mrq)
566.88%
Levered Free Cash Flow (ttm)
194.97M
Research Analysis: SHC
View MoreResearch Reports: SHC
View MoreRaising target price to $12.00
SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $12.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetWhat does Argus have to say about SHC?
SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetRaising target price to $11.00
SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetLowering target price to $10.00
SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $10.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target